Tenax Therapeutics (TENX) Revenue (2010 - 2015)

Tenax Therapeutics recorded quarterly Revenue of $49286.0 in Q2 2015, down 72.86% quarter-over-quarter from $181572.0 in Q2 2013.

Tenax Therapeutics' Revenue history runs 5 years deep, the most recent figure standing at $49286.0 for Q2 2015.

  • In Q2 2015, Revenue changed N/A year-over-year to $49286.0; the TTM figure through Jun 2016 stood at $49286.0 (down 94.9% YoY), while the FY2015 annual figure was $49286.0, changed N/A from the prior year.
  • Revenue came in at $49286.0 for Q2 2015 at Tenax Therapeutics, down from $181572.0 in the prior quarter.
  • In the past five years, Revenue ranged from a high of $514872.0 in Q4 2012 to a low of $24873.0 in Q3 2011.
  • A 4-year average of $151464.6 and a median of $95159.0 in 2011 frame the typical range for Revenue.
  • Across the five-year window, Revenue jumped 993.94% in 2012 and jumped 51.3% in 2013, its largest moves.
  • Tenax Therapeutics' Revenue stood at $95159.0 in 2011, then surged by 441.06% to $514872.0 in 2012, then sank by 64.73% to $181572.0 in 2013, then plunged by 72.86% to $49286.0 in 2015.
  • According to Business Quant data, Revenue over the past three periods registered $49286.0, $181572.0, and $221051.0 for Q2 2015, Q2 2013, and Q1 2013 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Revenue (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - -
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn 306.30 Mn
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - -
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn 2.99 Bn
7 Evaxion A 62.56 Bn 62.54 Bn - -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn 3.61 Bn
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn 1.17 Bn
10 Tenax Therapeutics 542.72 Mn 542.72 Mn - -

Historic Data

Download Data 🔒
DateValue
Jun 30, 2015 49,286.00
Apr 30, 2013 181,572.00
Jan 31, 2013 221,051.00
Oct 31, 2012 514,872.00
Jul 31, 2012 272,096.00
Apr 30, 2012 90,170.00
Jan 31, 2012 146,101.00
Oct 31, 2011 95,159.00
Jul 31, 2011 24,873.00
Apr 30, 2011 44,342.00
Jan 31, 2011 26,589.00
Oct 31, 2010 27,126.00